These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30015950)

  • 21. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMP9 inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via the PI3K/AKT signaling pathway.
    Song B; Li XF; Yao Y; Xu QQ; Meng XM; Huang C; Li J
    Int Immunopharmacol; 2019 Sep; 74():105685. PubMed ID: 31203157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
    Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C
    Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: role of the PI3K/AKT pathway and associated microRNAs.
    Banerjee N; Kim H; Krenek K; Talcott ST; Mertens-Talcott SU
    Nutr Res; 2015 Aug; 35(8):744-51. PubMed ID: 26194618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
    Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UNC5C‑knockdown enhances the growth and metastasis of breast cancer cells by potentiating the integrin α6/β4 signaling pathway.
    Yuan M; Xie F; Xia X; Zhong K; Lian L; Zhang S; Yuan L; Ye J
    Int J Oncol; 2020 Jan; 56(1):139-150. PubMed ID: 31789389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.
    Ren D; Jia L; Li Y; Gong Y; Liu C; Zhang X; Wang N; Zhao Y
    IUBMB Life; 2014 Apr; 66(4):300-8. PubMed ID: 24756995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
    Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
    Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.
    Wang K; Feng H; Ren W; Sun X; Luo J; Tang M; Zhou L; Weng Y; He TC; Zhang Y
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1687-96. PubMed ID: 21892652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog.
    Xu W; Wang W
    Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.
    Ren W; Sun X; Wang K; Feng H; Liu Y; Fei C; Wan S; Wang W; Luo J; Shi Q; Tang M; Zuo G; Weng Y; He T; Zhang Y
    Mol Biol Rep; 2014 Mar; 41(3):1373-83. PubMed ID: 24413988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA‑433 inhibits cell growth and induces apoptosis in human cervical cancer through PI3K/AKT signaling by targeting FAK.
    Xu J; Zhu W; Chen L; Liu L
    Oncol Rep; 2018 Dec; 40(6):3469-3478. PubMed ID: 30272334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes.
    Wang T; Zhang Z; Wang K; Wang J; Jiang Y; Xia J; Gou L; Liu M; Zhou L; He T; Zhang Y
    Oncotarget; 2017 May; 8(22):35890-35901. PubMed ID: 28415788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.